| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Alpha-Emitters and Targeted Alpha Therapy in Oncology: from Basic Science to Clinical Investigations
|
Makvandi, Mehran
|
|
2018
|
13 |
2 |
p. 189-203
|
article
|
| 2 |
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience
|
Purim, Ofer
|
|
2018
|
13 |
2 |
p. 217-226
|
article
|
| 3 |
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis
|
Schmidt, Elvira
|
|
2018
|
13 |
2 |
p. 205-216
|
article
|
| 4 |
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines
|
Restelli, Valentina
|
|
2018
|
13 |
2 |
p. 235-245
|
article
|
| 5 |
Extracellular Vesicles As miRNA Nano-Shuttles: Dual Role in Tumor Progression
|
Pucci, Marzia
|
|
2018
|
13 |
2 |
p. 175-187
|
article
|
| 6 |
Induction chemotherapy with the EXTREME regimen in frail patients with locally advanced head and neck squamous cell carcinoma
|
Cochin, Valérie
|
|
2018
|
13 |
2 |
p. 247-252
|
article
|
| 7 |
Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences
|
Davar, Diwakar
|
|
2018
|
13 |
2 |
p. 125-140
|
article
|
| 8 |
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study
|
Di Bartolomeo, Maria
|
|
2018
|
13 |
2 |
p. 227-234
|
article
|
| 9 |
Retreatment with Vismodegib after Progression in Advanced Basal Cell Carcinoma: First-Time Report of a Single-Institution Experience
|
Alfieri, Salvatore
|
|
2017
|
13 |
2 |
p. 253-256
|
article
|
| 10 |
The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
|
Hlavata, Zuzana
|
|
2018
|
13 |
2 |
p. 113-123
|
article
|
| 11 |
Treatment of EGFR T790M-Positive Non-Small Cell Lung Cancer
|
Choo, Joan Rou-En
|
|
2018
|
13 |
2 |
p. 141-156
|
article
|
| 12 |
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
|
DiGiacomo, Josh W.
|
|
2018
|
13 |
2 |
p. 157-173
|
article
|
Journal description